Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

a primary focus for the 2017 calendar year is completing work necessary to forge partnerships with larger pharmaceutical companies presently engaged with Cellceutix, some under Confidential Disclosure Agreements (CDAs). Should outcomes from ongoing clinical studies yield favorable results, the Company is optimistic that it will be able to capitalize on the data with respect to a partnership. Securing partnerships would generate substantial shareholder value, while also helping to advance the Company’s innovative drug candidates toward market approval, benefiting patients in need of additional safe and effective treatment options.

http://www.cellceutix.com/press-release/2017/2/15/y3616250ilexnq8enkoy8lelciljue

Good luck and GOD bless,

George